SLP2/PHB Aggregates in ALS Mouse Models and Patients: Implications Beyond CHCHD10-Associated Motor Neuron Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262210852 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Emmanuelle C Genin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Team "Mitochondria, Diseases and Aging", Institute for Research on Cancer and Aging, Nice (IRCAN), Inserm U1081, CNRS UMR7284, Université Côte d'Azur…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Membrane Proteins, Repressor Proteins, Protein Aggregation, Pathological. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation pour la Recherche Médicale, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder characterized by motor neuron (MN) degeneration, frequently overlapping with frontotemporal dementia (FTD). Protein aggregation is a hallmark of these disorders, yet the role of aggregates in ALS pathogenesis remains unclear. Previously, stomatin-like protein 2 (SLP2) and prohibitin (PHB) aggregates were identified in a model of CHCHD10-related ALS (Chchd10S59L/+ mice). This study raises the question of the presence and possible involvement of these aggregates in ALS beyond CHCHD10-associated motor neuron disease (MND). Using immunohistofluorescence, we analyzed SLP2/PHB expression in the spinal MNs and hippocampus of two ALS mouse models: FusΔNLS and Sod1G86R. Additionally, post-mortem spinal cord tissues from 27 ALS and ALS-FTD patients were analyzed. SLP2/PHB aggregates were identified in spinal MNs and the hippocampus of FusΔNLS mice but not in Sod1G86R mice. In ALS patients, SLP2/PHB aggregation was observed in four cases, including two with C9ORF72 mutations. Interestingly, aggregates were absent in SOD1-associated ALS patients. These findings suggest that SLP2/PHB aggregation is not specific to CHCHD10 variants but may contribute to the pathogenesis of ALS from different origins. The age-related accumulation of these aggregates highlights their potential role in disease progression and as therapeutic targets. Future studies should investigate their mechanistic contributions across different ALS subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Team "Mitochondria, Diseases and Aging", Institute for Research on Cancer and Aging, Nice (IRCAN), Inserm U1081, CNRS UMR7284, Université Côte d'Azur (UniCA), 06107 Nice, France.
- Centre de Recherche en Biomédecine, Strasbourg Translational Neuroscience and Psychiatry, UMR-S1329, Inserm, Université de Strasbourg, 67000 Strasbourg, France.
- Department of Medical Genetics & Reference Centre for Mitochondrial Disease, Nice Universitary Hospital, 06202 Nice, France.
ORCID-Profile: Emmanuelle C Genin
Förderung
- Fondation pour la Recherche Médicale
- Agence Nationale de la Recherche
Zitieren
APA
Genin, E. C., Lespinasse, F., Mauri-Crouzet, A., Dupuis, L., & Paquis-Flucklinger, V. (2025). SLP2/PHB Aggregates in ALS Mouse Models and Patients: Implications Beyond CHCHD10-Associated Motor Neuron Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210852
Vancouver
Genin EC, Lespinasse F, Mauri-Crouzet A, Dupuis L, Paquis-Flucklinger V. SLP2/PHB Aggregates in ALS Mouse Models and Patients: Implications Beyond CHCHD10-Associated Motor Neuron Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210852
BibTeX
@article{Genin2025,
author = {Genin, Emmanuelle C and Lespinasse, Françoise and Mauri-Crouzet, Alessandra and Dupuis, Luc and Paquis-Flucklinger, Véronique},
title = {SLP2/PHB Aggregates in ALS Mouse Models and Patients: Implications Beyond CHCHD10-Associated Motor Neuron Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262210852}
}
EUVIMED